Predicting COVID-19 vaccine take-up: Moving beyond demographics.
Predicting COVID-19 vaccine take-up: Moving beyond demographics.
复制标题
DOI:
10.1016/j.bbi.2021.03.021
复制
发表时间:
2021-07
期刊:
影响因子:
--
通讯作者:
Deary IJ
中科院分区:
文献类型:
--
作者:
Batty GD;Deary IJ
As the present pandemic has unfolded, principal investigators on existing UK population-based studies–the five birth cohorts (1946, 1958, 1970, Millennium, Next Steps), the English Longitudinal Study of Ageing, the Avon Longitudinal Study of Parents and Children, and Generation Scotland, amongst others–often at the behest of domestic funding agencies, have scrambled to conduct COVID-19-orientated surveys. Coupled with data gathered pre-pandemic, these are wellplaced to quantify the economic, social, and health consequences of illness, quarantine, and the lockdown more broadly,(Pierce et al., 2020) although, whether the resources invested across this large portfolio, as opposed to a greater focus on bespoke projects, will have long term value is debatable. While appearing in a journal more accustomed to high-resolution studies in the psychoneuroimmunology field, the paper in this issue by Elaine Robertson and others (Robertson et al., 2021) on the prevalence and predictors of COVID-19 vaccine hesitancy is a useful contribution using data from a study nested within another established UK cohort, Understanding Society (Burton et al., 2020). Herd immunity refers to the notion that, once a stated majority of a population becomes immune to an infectious disease, the probability of between-person spread is substantially diminished because those who remain at risk are indirectly protected owing to the low prevalence of the disease (Desai and Majumder, 2020). Much-debated in the context of this pandemic, one view is that these conditions should be achieved by national lockdown with vaccination, while another advocates for segmentation and protection of the most vulnerable groups with the remainder returning to more normal life with herd immunity realised via community infection (Wise, 2020). Opting for the former, the UK government has distributed vaccines at unprecedented pace and scale in an initiative that at least approaches their aim of being ‘world beating’when multiple other responses have been highly flawed (Looi, 2020). As efforts continue to attain herd immunity, reports of vaccine hesitancy–the refusal or delay in being vaccinated despite safety assurance and availability (MacDonald, 2015)–by no means unique to the present pandemic,(Burger et al., 2021) are concerning, and require rapid quantification and understanding.The unveiling of several new efficacious vaccines in recent months, rendering real what was once a distant-seeming aspiration, may have contributed to the marked secular reduction in hesitancy seen across many countries (YouGov, 2021). With data on intentionality in Understanding Society serendipitously being collected immediately following the announcement of the successful testing of the Oxford University/AstraZeneca jab, the study by Robertson et al.(Robertson et al., 2021) therefore offers estimates when vaccination was a reality. In the full cohort, the prevalence of vaccine hesitancy was 18%, but this conceals stark differences across population sub-groups. Owing to its size and purposeful sampling, rarely amongst UK studies (Bécares et al., 2020), Understanding Society has a reasonable representation of people from diverse ethnic backgrounds. Whereas not every minority group was more likely to be vaccine-hesitant relative to White British/Irish study members (16%)–people defining themselves as East Asian British had the lowest prevalence (14%)–those identifying as Black British (72%) had the highest levels of reluctance, with Pakistani/Bangladeshi groups being the next most hesitant (42%)(Robertson et al., 2021). Concern about the unknown longer term side-effects was the primary …
登录
查看更多内容
影响因子:
7.8
作者:
Wang J;Jing R;Lai X;Zhang H;Lyu Y;Knoll MD;Fang H
通讯作者:
Fang H
影响因子:
15.1
作者:
Lassale, Camille;Gaye, Bamba;Batty, G. David
通讯作者:
Batty, G. David
影响因子:
3
作者:
Deary, Ian J.;Gale, Catharine R.;Price, Jacqueline F.
通讯作者:
Price, Jacqueline F.
影响因子:
6.3
作者:
Gale CR;Deary IJ;Wardle J;Zaninotto P;Batty GD
通讯作者:
Batty GD
DOI:
10.15585/mmwr.mm7006e3
发表时间:
2021-02-12
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Nguyen KH;Srivastav A;Razzaghi H;Williams W;Lindley MC;Jorgensen C;Abad N;Singleton JA
通讯作者:
Singleton JA